Clinical Trials Directory

Trials / Completed

CompletedNCT00547508

To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking

A Randomized, Double-Blind, Parallel, Placebo-Controlled Study in Men With Erectile Dysfunction to Evaluate the Efficacy and Safety of Tadalafil When Sexual Attempts Occur at Specific Time Points After Dosing

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
485 (actual)
Sponsor
Eli Lilly and Company · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study to see how effective different doses of tadalafil are for getting and keeping an erection when sex is attempted after a certain number of hours.

Conditions

Interventions

TypeNameDescription
DRUGtadalafil10 mg tablet taken orally, no more than once a day, at anytime during the 2-4 week equilibration phase and then 24 hours prior to sexual intercourse for 4-6 weeks in the assessment phase
DRUGplaceboPlacebo tablet taken by mouth, no more than once a day, anytime during the 2-4 week equilibration phase and then 24 hours prior to sexual intercourse for 4-6 weeks in the assessment phase
DRUGtadalafil20 mg tablet taken orally, no more than once a day, at anytime during the 2-4 week equilibration phase and then 24 hours prior to sexual intercourse for 4-6 weeks in the assessment phase
DRUGtadalafil20 mg tablet taken orally, no more than once a day, at anytime during the 2-4 week equilibration phase and then 36 hours prior to sexual intercourse for 4-6 weeks in the assessment phase
DRUGtadalafil10 mg tablet taken orally, no more than once a day, at anytime during the 2-4 week equilibration phase and then 36 hours prior to sexual intercourse for 4-6 weeks in the assessment phase
DRUGplaceboPlacebo tablet taken by mouth, no more than once a day, anytime during the 2-4 week equilibration phase and then 36 hours prior to sexual intercourse for 4-6 weeks in the assessment phase

Timeline

Start date
2002-10-01
Completion
2003-09-01
First posted
2007-10-22
Last updated
2007-10-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00547508. Inclusion in this directory is not an endorsement.